Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[ESWL in hemophilia B].

R Schlick1, M Djamilian, W de Riese

  • 1Klinik für Urologie, Medizinische Hochschule Hannover.

Der Urologe. Ausg. A
|July 1, 1992
PubMed
Summary

Extracorporeal shock wave lithotripsy (ESWL) can cause bleeding, especially in patients with blood disorders. This study shows successful ESWL treatment for a patient with hemophilia B, demonstrating its potential safety with proper management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[In memory of Professor Dr. med. Dr. h.c. Jürgen Sökeland : * 25 September 1933 † 27 November 2023].

Urologie (Heidelberg, Germany)·2024
Same author

Reduced Expression of the Cell Cycle Regulator p27<sup>Kip1</sup> within the Invasion Front of Renal Cell Carcinomas Proved to be a Significant Marker for Disease-specific Survival.

Cancer genomics & proteomics·2019
Same author

[A rare renal tumour : Ectopic thyroid tissue in the kidney].

Der Urologe. Ausg. A·2018
Same author

Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
Same author

Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer.

Cell death & disease·2014
Same author

[Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database].

Der Urologe. Ausg. A·2013

Area of Science:

  • Urology
  • Nephrology
  • Hematology

Background:

  • Extracorporeal shock wave lithotripsy (ESWL) is a common treatment for nephrolithiasis (kidney stones).
  • A significant risk associated with ESWL is intra- and perirenal bleeding, occurring even in patients with normal blood parameters.
  • ESWL is generally contraindicated in patients with blood disorders due to increased bleeding risks.

Observation:

  • A case report details a patient with hemophilia B and a large renal pelvic stone.
  • The patient underwent two sessions of ESWL.
  • Sufficient blood factor substitution was administered prior to and during ESWL treatment.

Findings:

  • The patient was successfully rendered stone-free 25 days after the first ESWL session.
  • This case demonstrates that ESWL can be a viable treatment option for nephrolithiasis in patients with hemophilia B.
  • The treatment was effective despite the inherent bleeding risks associated with the patient's condition.

Implications:

  • ESWL may be considered for nephrolithiasis in patients with hemophilia B, provided adequate substitution therapy is administered.
  • Careful patient selection and management are crucial when considering ESWL in patients with bleeding disorders.
  • This case contributes to the literature supporting the safe application of ESWL in specific hematological conditions.

Related Experiment Videos